Therapeutic approach for COVID-19: The power of herbal medicine
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/8907 |
Resumo: | The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19. |
id |
UNIFEI_315223720a529616fbea308d8c1cc858 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/8907 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Therapeutic approach for COVID-19: The power of herbal medicineEnfoque terapéutico para COVID-19: El poder de la medicina herbalAbordagem terapêutica para COVID-19: O poder da medicina herbalPlantas medicinaisHomeopáticosFloraisSARS-CoV-2Tratamento complementar.Medicinal plantsHomeopathicsFloralsSARS-CoV-2Complementary treatment.Plantas medicinalesHomeopáticosFloralesSARS-CoV-2Tratamiento complementario.The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19.El objetivo de este trabajo fue evaluar si las plantas medicinales como ingredientes activos de los medicamentos herbales, homeopáticos y florales comercializados en Brasil, tenían un uso potencial como estrategia terapéutica para la prevención, tratamiento y cura del COVID-19. Este estudio tomó en cuenta productos comercializados y regulados por la legislación brasileña con reclamos tales como: inmunomoduladores, antivirales y mejoría de síntomas relacionados con la deficiencia del sistema respiratorio, los cuales se calcularon las frecuencias absolutas (n) y relativas (%). Además, se utilizaron las bases de datos PubMed®, Web of Science® y SciVerse Scopus® para buscar en la literatura con el fin de obtener los reclamos científicos de las plantas que se encuentran en las formulaciones de los productos evaluados, teniendo en cuenta los síntomas típicos del COVID-19. Se encontraron 113 productos, de los cuales el 65% eran medicamentos a base de hierbas, el 27% medicamentos homeopáticos y el 7% florales. Fueron 13 plantas medicinales con una frecuencia absoluta ≥ 5, en las que se encontró evidencia científica sobre su uso medicinal, como terapia complementaria en el tratamiento de síntomas relacionados con COVID-19.O objetivo deste trabalho foi avaliar se as plantas medicinais, como princípios ativos de medicamentos fitoterápicos, homeopáticos e florais comercializados no Brasil, têm potencial uso como estratégia terapêutica para prevenção, tratamento e cura do COVID-19. Este estudo considerou produtos comercializados e regulamentados pela legislação brasileira com reivindicações como: imunomoduladores, antivirais e melhora de sintomas relacionados à deficiência do aparelho respiratório, sendo calculadas frequências absolutas (n) e relativas (%). Além disso, os bancos de dados PubMed®, Web of Science® e SciVerse Scopus® foram utilizados em busca na literatura para obter afirmações científicas das plantas encontradas nas formulações dos produtos avaliados, considerando sintomas típicos da COVID-19. Foram encontrados 113 produtos, dos quais 65% eram fitoterápicos, 27% medicamentos homeopáticos e 7% florais. Houve 13 plantas medicinais com frequência absoluta ≥ 5, nas quais foram encontradas evidências científicas quanto a seu uso medicinal como terapia complementar no tratamento dos sintomas relacionados à COVID-19.Research, Society and Development2020-10-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/890710.33448/rsd-v9i10.8907Research, Society and Development; Vol. 9 No. 10; e6789108907Research, Society and Development; Vol. 9 Núm. 10; e6789108907Research, Society and Development; v. 9 n. 10; e67891089072525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/8907/8071Copyright (c) 2020 Danilo José Machado de Abreu; Hanna Elisia Araújo de Barros; Caio Vinicius Lima Natarelli; Alice Pereira Zanzini; Eduardo Valério de Barros Vilas Boas; Roberta Hilsdorf Piccoli; Elisângela Elena Nunes Carvalhohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAbreu, Danilo José Machado deBarros, Hanna Elisia Araújo de Natarelli, Caio Vinicius Lima Zanzini, Alice Pereira Boas, Eduardo Valério de Barros Vilas Piccoli, Roberta Hilsdorf Carvalho, Elisângela Elena Nunes 2020-10-31T12:03:23Zoai:ojs.pkp.sfu.ca:article/8907Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:31:16.722859Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Therapeutic approach for COVID-19: The power of herbal medicine Enfoque terapéutico para COVID-19: El poder de la medicina herbal Abordagem terapêutica para COVID-19: O poder da medicina herbal |
title |
Therapeutic approach for COVID-19: The power of herbal medicine |
spellingShingle |
Therapeutic approach for COVID-19: The power of herbal medicine Abreu, Danilo José Machado de Plantas medicinais Homeopáticos Florais SARS-CoV-2 Tratamento complementar. Medicinal plants Homeopathics Florals SARS-CoV-2 Complementary treatment. Plantas medicinales Homeopáticos Florales SARS-CoV-2 Tratamiento complementario. |
title_short |
Therapeutic approach for COVID-19: The power of herbal medicine |
title_full |
Therapeutic approach for COVID-19: The power of herbal medicine |
title_fullStr |
Therapeutic approach for COVID-19: The power of herbal medicine |
title_full_unstemmed |
Therapeutic approach for COVID-19: The power of herbal medicine |
title_sort |
Therapeutic approach for COVID-19: The power of herbal medicine |
author |
Abreu, Danilo José Machado de |
author_facet |
Abreu, Danilo José Machado de Barros, Hanna Elisia Araújo de Natarelli, Caio Vinicius Lima Zanzini, Alice Pereira Boas, Eduardo Valério de Barros Vilas Piccoli, Roberta Hilsdorf Carvalho, Elisângela Elena Nunes |
author_role |
author |
author2 |
Barros, Hanna Elisia Araújo de Natarelli, Caio Vinicius Lima Zanzini, Alice Pereira Boas, Eduardo Valério de Barros Vilas Piccoli, Roberta Hilsdorf Carvalho, Elisângela Elena Nunes |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Abreu, Danilo José Machado de Barros, Hanna Elisia Araújo de Natarelli, Caio Vinicius Lima Zanzini, Alice Pereira Boas, Eduardo Valério de Barros Vilas Piccoli, Roberta Hilsdorf Carvalho, Elisângela Elena Nunes |
dc.subject.por.fl_str_mv |
Plantas medicinais Homeopáticos Florais SARS-CoV-2 Tratamento complementar. Medicinal plants Homeopathics Florals SARS-CoV-2 Complementary treatment. Plantas medicinales Homeopáticos Florales SARS-CoV-2 Tratamiento complementario. |
topic |
Plantas medicinais Homeopáticos Florais SARS-CoV-2 Tratamento complementar. Medicinal plants Homeopathics Florals SARS-CoV-2 Complementary treatment. Plantas medicinales Homeopáticos Florales SARS-CoV-2 Tratamiento complementario. |
description |
The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-10-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/8907 10.33448/rsd-v9i10.8907 |
url |
https://rsdjournal.org/index.php/rsd/article/view/8907 |
identifier_str_mv |
10.33448/rsd-v9i10.8907 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/8907/8071 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 10; e6789108907 Research, Society and Development; Vol. 9 Núm. 10; e6789108907 Research, Society and Development; v. 9 n. 10; e6789108907 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052660830961664 |